Bros. Advisors Lp Baker's Net Worth
Bros. Advisors Lp Baker's net worth is estimated to be at least $3,025,016,288.85 as of 05/22/2025. CoreStreet's estimation of Bros. Advisors Lp Baker's net worth is based on their sale of stock and current holding of stock.
Bros. Advisors Lp Baker is Director at Immunocore Holdings Ltd. They have executed at least 112 trades of stock as per SEC Form 4 filings. Their most recent trade was for 807,338 units of IMCR stock on 03/17/2025. Their biggest sale was on 12/09/2024 when they sold 1,037,017 units of BeiGene Ltd stock for $194,202,173.59. They typically trade 8 times per year.
Total value of insider buys:
- $2,398,981,146.76
Total value of insider sells:
- $626,035,142.09
Most recent insider trade:
- March 17, 2025
Bros. Advisors Lp Baker's Insider Trading History
| Immunocore Holdings Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 17, 2025 | Director | 807,338 | $29.72 | Buy | $23,994,085.36 |
| BeiGene, Ltd. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 28, 2025 | Director | 732,827 | $260.00 | Sell | $190,535,020.00 |
| Kala Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 30, 2024 | Major Shareholder | 310,559 | $6.44 | Buy | $1,999,999.96 |
| Bicycle Therapeutics Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2024 | Director | 500,000 | $15.34 | Buy | $7,670,000.00 |
Dec. 13, 2024 | Director | 985,397 | $13.76 | Buy | $13,559,062.72 |
| BeiGene Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 9, 2024 | Director | 1,037,017 | $187.27 | Sell | $194,202,173.59 |
Jan. 4, 2021 | Director | 121,154 | $220.50 | Sell | $26,714,457.00 |
Aug. 2, 2018 | Director | 5,814,100 | $108.00 | Buy | $627,922,800.00 |
Jan. 18, 2018 | Director | 1,980,198 | $101.00 | Buy | $199,999,998.00 |
Aug. 11, 2017 | Director | 176,056 | $71.00 | Buy | $12,499,976.00 |
Nov. 18, 2016 | Director | 1,760,495 | $32.00 | Buy | $56,335,840.00 |
Feb. 8, 2016 | Director | 1,912,680 | $24.00 | Buy | $45,904,320.00 |
| IGM Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 28, 2024 | Director | 97,473 | $9.62 | Buy | $937,690.26 |
March 26, 2024 | Director | 270,000 | $8.26 | Buy | $2,230,200.00 |
Dec. 15, 2023 | Director | 288,007 | $6.55 | Buy | $1,886,445.85 |
Dec. 13, 2023 | Director | 87,316 | $5.96 | Buy | $520,403.36 |
Sept. 20, 2019 | Director | 3,144,000 | $16.00 | Buy | $50,304,000.00 |
| Madrigal Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 13, 2023 | Director | 81,159 | $219.39 | Buy | $17,805,473.01 |
Nov. 21, 2023 | Director | 64,350 | $188.47 | Buy | $12,128,044.50 |
Nov. 17, 2023 | Director | 46,370 | $174.70 | Buy | $8,100,839.00 |
Nov. 14, 2023 | Director | 34,188 | $156.42 | Buy | $5,347,686.96 |
| Atreca Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 19, 2023 | Major Shareholder | 274,739 | $0.40 | Sell | $109,895.60 |
| Neoleukin Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 17, 2023 | Director | 166,942 | $0.69 | Buy | $115,189.98 |
Aug. 15, 2023 | Director | 1,888,800 | $0.63 | Buy | $1,189,944.00 |
July 7, 2020 | Director | 424,000 | $15.25 | Buy | $6,466,000.00 |
Dec. 20, 2019 | Director | 3,017,542 | $8.40 | Buy | $25,347,352.80 |
Aug. 7, 2019 | Director | 371,525 | $3.00 | Buy | $1,114,575.00 |
| ACADIA Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 23, 2023 | Director | 209,053 | $25.41 | Buy | $5,312,036.73 |
March 18, 2020 | Director | 1,050,000 | $33.30 | Buy | $34,965,000.00 |
March 16, 2020 | Director | 694,303 | $31.51 | Buy | $21,877,487.53 |
Sept. 20, 2019 | Director | 1,562,500 | $40.00 | Buy | $62,500,000.00 |
Nov. 30, 2018 | Director | 11,764,705 | $17.00 | Buy | $199,999,985.00 |
Sept. 20, 2018 | Director | 1,210,776 | $18.70 | Buy | $22,641,511.20 |
Aug. 10, 2016 | Director | 1,303,030 | $33.00 | Buy | $42,999,990.00 |
April 1, 2016 | Director | 1,449,090 | $27.08 | Buy | $39,241,357.20 |
March 5, 2014 | Director | 526,316 | $28.50 | Buy | $15,000,006.00 |
| Entrada Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2022 | Major Shareholder | 38,304 | $6.41 | Buy | $245,528.64 |
June 2, 2022 | Major Shareholder | 2,643 | $5.82 | Buy | $15,382.26 |
May 23, 2022 | Major Shareholder | 7,837 | $5.99 | Buy | $46,943.63 |
May 20, 2022 | Major Shareholder | 16,849 | $5.84 | Buy | $98,398.16 |
May 18, 2022 | Major Shareholder | 34,433 | $6.00 | Buy | $206,598.00 |
May 16, 2022 | Major Shareholder | 19,000 | $5.83 | Buy | $110,770.00 |
| Kodiak Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2022 | Director | 303,917 | $7.77 | Buy | $2,361,435.09 |
June 2, 2022 | Director | 166,232 | $7.67 | Buy | $1,274,999.44 |
May 18, 2022 | Director | 223,766 | $5.97 | Buy | $1,335,883.02 |
May 16, 2022 | Director | 122,100 | $5.72 | Buy | $698,412.00 |
Feb. 17, 2022 | Director | 300,000 | $54.56 | Buy | $16,368,000.00 |
Feb. 15, 2022 | Director | 5,800 | $54.16 | Buy | $314,128.00 |
Jan. 31, 2022 | Director | 30,148 | $57.22 | Buy | $1,725,068.56 |
Jan. 27, 2022 | Director | 262,259 | $51.76 | Buy | $13,574,525.84 |
Jan. 24, 2022 | Director | 362,197 | $57.72 | Buy | $20,906,010.84 |
Jan. 21, 2022 | Director | 133,414 | $56.80 | Buy | $7,577,915.20 |
Sept. 30, 2021 | Director | 86,932 | $95.83 | Buy | $8,330,693.56 |
Sept. 15, 2021 | Director | 30,685 | $94.39 | Buy | $2,896,357.15 |
Sept. 7, 2021 | Director | 57,501 | $93.31 | Buy | $5,365,418.31 |
Aug. 19, 2021 | Director | 83,648 | $87.56 | Buy | $7,324,218.88 |
Aug. 17, 2021 | Director | 8,164 | $85.90 | Buy | $701,287.60 |
Aug. 13, 2021 | Director | 38,264 | $88.66 | Buy | $3,392,486.24 |
Aug. 11, 2021 | Director | 53,523 | $86.11 | Buy | $4,608,865.53 |
Sept. 24, 2020 | Director | 36,020 | $52.02 | Buy | $1,873,760.40 |
Sept. 22, 2020 | Director | 74,958 | $50.67 | Buy | $3,798,121.86 |
Sept. 8, 2020 | Director | 322,979 | $47.43 | Buy | $15,318,893.97 |
Sept. 3, 2020 | Director | 123,883 | $47.97 | Buy | $5,942,667.51 |
Aug. 21, 2020 | Director | 139,044 | $48.63 | Buy | $6,761,709.72 |
Aug. 19, 2020 | Director | 3,869 | $46.99 | Buy | $181,804.31 |
March 18, 2020 | Director | 150,000 | $38.18 | Buy | $5,727,000.00 |
March 16, 2020 | Director | 104,600 | $39.97 | Buy | $4,180,862.00 |
Feb. 26, 2020 | Director | 100,000 | $57.99 | Buy | $5,799,000.00 |
Feb. 24, 2020 | Director | 71,123 | $57.56 | Buy | $4,093,839.88 |
Dec. 6, 2019 | Director | 1,902,173 | $64.47 | Buy | $122,633,093.31 |
| Incyte Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 10, 2022 | Director | 218,563 | $73.13 | Buy | $15,983,512.19 |
March 8, 2022 | Director | 100,000 | $70.67 | Buy | $7,067,000.00 |
Feb. 22, 2022 | Director | 99,800 | $68.07 | Buy | $6,793,386.00 |
Feb. 17, 2022 | Director | 292,972 | $67.74 | Buy | $19,845,923.28 |
Dec. 17, 2021 | Director | 1,075,872 | $72.80 | Buy | $78,323,481.60 |
Dec. 15, 2021 | Director | 350,332 | $71.51 | Buy | $25,052,241.32 |
May 28, 2020 | Director | 2 | $102.55 | Buy | $205.10 |
Sept. 8, 2017 | Director | 100,000 | $132.00 | Buy | $13,200,000.00 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 30, 2021 | Director | 301,444 | $160.33 | Sell | $48,330,516.52 |
May 8, 2020 | Director | 500,000 | $158.50 | Sell | $79,250,000.00 |
May 8, 2018 | Director | 460,651 | $53.34 | Buy | $24,571,124.34 |
May 4, 2018 | Director | 204,537 | $52.68 | Buy | $10,775,009.16 |
May 1, 2018 | Director | 306,917 | $51.36 | Buy | $15,763,257.12 |
Feb. 1, 2018 | Director | 3,846,153 | $52.00 | Buy | $199,999,956.00 |
| Talis Biomedical Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 18, 2021 | Director | 50,000 | $4.37 | Buy | $218,500.00 |
| Hookipa Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 23, 2019 | Insider | 892,857 | $14.00 | Buy | $12,499,998.00 |
| Kiniksa Pharmaceuticals Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 29, 2018 | Director | 3,000,000 | $18.00 | Buy | $54,000,000.00 |
| InVitae Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 28, 2018 | Major Shareholder | 1,111,111 | $4.50 | Buy | $4,999,999.50 |
Nov. 17, 2016 | Major Shareholder | 733,333 | $6.00 | Buy | $4,399,998.00 |
| Bellicum Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 19, 2018 | Major Shareholder | 880,735 | $8.20 | Sell | $7,222,027.00 |
Jan. 17, 2018 | Major Shareholder | 260,600 | $8.63 | Sell | $2,248,978.00 |
March 24, 2017 | Major Shareholder | 166,666 | $12.00 | Buy | $1,999,992.00 |
| Idera Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 26, 2017 | Director | 8,000,000 | $1.50 | Buy | $12,000,000.00 |
| Rhythm Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 5, 2017 | Insider | 885,000 | $17.00 | Buy | $15,045,000.00 |
| BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2016 | Major Shareholder | 4,046,590 | $5.00 | Sell | $20,232,950.00 |
Jan. 28, 2016 | major shareholder | 88,345 | $6.95 | Buy | $613,997.75 |
Jan. 22, 2016 | major shareholder | 106,800 | $7.28 | Buy | $777,504.00 |
Jan. 20, 2016 | major shareholder | 52,695 | $6.87 | Buy | $362,014.65 |
Jan. 19, 2016 | major shareholder | 92,200 | $7.12 | Buy | $656,464.00 |
Jan. 15, 2016 | major shareholder | 200,000 | $7.46 | Buy | $1,492,000.00 |
| Mirati Ther | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 9, 2016 | Major Shareholder | 999,358 | $9.41 | Sell | $9,403,958.78 |
Sept. 16, 2015 | Major Shareholder | 150,000 | $45.00 | Buy | $6,750,000.00 |
Jan. 29, 2015 | Major Shareholder | 425,000 | $20.00 | Buy | $8,500,000.00 |
| Intellia Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 11, 2016 | Insider | 200,000 | $18.00 | Buy | $3,600,000.00 |
| XOMA Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 22, 2015 | Insider | 11,000,000 | $1.09 | Sell | $11,990,000.00 |
Jan. 6, 2015 | Director | 2,215,400 | $3.81 | Sell | $8,440,674.00 |
Dec. 30, 2014 | Director | 744,000 | $3.67 | Sell | $2,730,480.00 |
Dec. 19, 2014 | Director | 1,605,100 | $4.26 | Sell | $6,837,726.00 |
Dec. 16, 2014 | Director | 1,033,800 | $4.46 | Sell | $4,610,748.00 |
Dec. 9, 2014 | Director | 392,353 | $4.62 | Sell | $1,812,670.86 |
Dec. 4, 2014 | Director | 2,372,206 | $4.79 | Sell | $11,362,866.74 |
Aug. 19, 2013 | Director | 2,757,791 | $3.62 | Buy | $9,983,203.42 |